## Clinical Context This patient has **Barrett's metaplasia of the bronchus** (intestinal-type metaplasia) with **CIN 2 (cervical intraepithelial neoplasia grade 2)** dysplasia. This is a precancerous lesion with significant risk of progression to invasive carcinoma. ## Key Point: **Dysplasia is a reversible lesion if the causative stimulus (smoking) is removed early, but requires surveillance.** CIN 2 dysplasia carries a 30–40% risk of progression to invasive cancer within 5 years if untreated. ## Management Algorithm for Bronchial Dysplasia ```mermaid flowchart TD A[Bronchial biopsy shows dysplasia]:::outcome --> B{Grade of dysplasia?}:::decision B -->|CIN 1 Low-grade| C[Smoking cessation + repeat bronchoscopy in 6 months]:::action B -->|CIN 2 Moderate| D[Smoking cessation + repeat bronchoscopy in 3 months]:::action B -->|CIN 3 High-grade| E[Consider photodynamic therapy or surgical resection]:::action B -->|Invasive carcinoma| F[Staging + definitive treatment]:::urgent C --> G{Regression?}:::decision D --> G G -->|Yes| H[Continue surveillance]:::action G -->|No/Progression| I[Escalate intervention]:::urgent ``` ## High-Yield: **CIN 2 dysplasia management:** Aggressive smoking cessation + close endoscopic surveillance every 3 months. If dysplasia persists or progresses to CIN 3, consider photodynamic therapy (PDT) or surgical resection. ## Clinical Pearl: Metaplasia itself (intestinal-type epithelium) is **not cancer**—it is an adaptive response to chronic irritation. However, dysplasia superimposed on metaplasia is a **precancerous state** requiring active surveillance and intervention. ## Why Option 0 is Correct - Repeat bronchoscopy in 3 months allows assessment of dysplasia grade progression and guides escalation to PDT or surgery if needed. - Smoking cessation is mandatory but must be paired with surveillance because dysplasia may not fully regress. - This follows the standard surveillance protocol for CIN 2 in the respiratory tract. ## Distinction from Other Scenarios | Dysplasia Grade | Next Step | Rationale | |---|---|---| | **CIN 1 (Low-grade)** | Smoking cessation + repeat in 6 months | Often regresses with cessation alone | | **CIN 2 (Moderate)** | Smoking cessation + repeat in 3 months | Higher progression risk; closer surveillance | | **CIN 3 (High-grade)** | PDT or surgical resection | ~90% risk of progression to invasive cancer | | **Invasive carcinoma** | Staging + curative surgery/chemo/RT | No longer a precancerous lesion |
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.